Axogen, Inc. (AXGN)
55.93
+0.53
(+0.96%)
USD |
NASDAQ |
Nov 13, 16:00
56.10
+0.17
(+0.30%)
Pre-Market: 19:59
Axogen Enterprise Value : 3.010B for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 3.010B |
| November 12, 2026 | 2.978B |
| November 11, 2026 | 3.171B |
| November 10, 2026 | 2.709B |
| November 09, 2026 | 2.694B |
| November 06, 2026 | 2.657B |
| November 05, 2026 | 2.581B |
| November 04, 2026 | 2.736B |
| November 03, 2026 | 2.626B |
| November 02, 2026 | 2.647B |
| October 30, 2026 | 2.618B |
| October 29, 2026 | 2.634B |
| October 28, 2026 | 2.611B |
| October 27, 2026 | 1.907B |
| October 26, 2026 | 1.940B |
| October 23, 2026 | 1.943B |
| October 22, 2026 | 1.860B |
| October 21, 2026 | 1.848B |
| October 20, 2026 | 1.830B |
| October 19, 2026 | 1.774B |
| October 16, 2026 | 1.737B |
| October 15, 2026 | 1.797B |
| October 14, 2026 | 1.768B |
| October 13, 2026 | 1.830B |
| October 12, 2026 | 1.886B |
| Date | Value |
|---|---|
| October 09, 2026 | 1.827B |
| October 08, 2026 | 1.830B |
| October 07, 2026 | 1.822B |
| October 06, 2026 | 1.838B |
| October 05, 2026 | 1.892B |
| October 02, 2026 | 1.903B |
| October 01, 2026 | 2.054B |
| September 30, 2026 | 2.173B |
| September 29, 2026 | 2.184B |
| September 28, 2026 | 2.233B |
| September 25, 2026 | 2.235B |
| September 24, 2026 | 2.231B |
| September 23, 2026 | 2.231B |
| September 22, 2026 | 2.297B |
| September 21, 2026 | 2.371B |
| September 18, 2026 | 2.280B |
| September 17, 2026 | 2.336B |
| September 16, 2026 | 2.345B |
| September 15, 2026 | 2.320B |
| September 14, 2026 | 2.256B |
| September 11, 2026 | 2.169B |
| September 10, 2026 | 2.152B |
| September 09, 2026 | 2.443B |
| September 08, 2026 | 2.412B |
| September 04, 2026 | 2.497B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Senseonics Holdings, Inc. | 515.42M |
| Tandem Diabetes Care, Inc. | 1.693B |
| Accuray, Inc. | 101.26M |
| Orthofix Medical, Inc. | 467.34M |
| ResMed, Inc. | 33.27B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 2.334M |
| Revenue (Quarterly) | 75.83M |
| Total Expenses (Quarterly) | 73.50M |
| EPS Diluted (Quarterly) | 0.0379 |
| Gross Profit Margin (Quarterly) | 74.81% |
| Profit Margin (Quarterly) | 3.08% |
| Earnings Yield | -1.16% |
| Normalized Earnings Yield | -0.6987 |